Dr Zeina Nahleh speaks to ecancer about the OlympiA study.
Initially, she talks about the background and methodology of the study. Dr Nahleh then explains the key results of this study.
She concludes by discussing the future impact this study can have on treating and screening BRCA mutated breast cancer.
Watch the meeting in full by following the links below: